How “age-friendly” are deprescribing interventions? A scoping review of deprescribing trials

Authors

Jinjiao Wang, University of Rochester
Jenny Y. Shen, University of Rochester
Yeates Conwell, University of Rochester
Eric J. Podsiadly, University of Rochester
Thomas V. Caprio, University of Rochester
Kobi T. Nathan, St. John Fisher UniversityFollow
Fang Yu, Arizona State University
Erika E. Ramsdale, University of Rochester Medical Center
Donna M. Fick, Penn State University
Amanda S. Mixon, Vanderbilt University Medical Center
Sandra F. Simmons, Vanderbilt University Medical Center

Document Type

Article

Publication Date

10-11-2022

Abstract

To assess how age-friendly deprescribing trials are regarding intervention design and outcome assessment. Reduced use of potentially inappropriate medications (PIMs) can be addressed by deprescribing—a systematic process of discontinuing and/or reducing the use of PIMs. The 4Ms—“Medication”, “Mentation”, “Mobility”, and “What Matters Most” to the person—can be used to guide assessment of age-friendliness of deprescribing trials.

DOI

https://doi.org/10.1111/1475-6773.14083

Publication Information

Wang, Jinjiao; Shen, Jenny Y.; Conwell, Yeates; Podsiadly, Eric J.; Caprio, Thomas V.; Nathan, Kobi T.; Yu, Fang; Ramsdale, Erika E.; Fick, Donna M.; Mixon, Amanda S.; and Simmons, Sandra F. (2022). "How “age-friendly” are deprescribing interventions? A scoping review of deprescribing trials." Health Services Research 58.S1, 123-138.

Please note that the Publication Information provides general citation information and may not be appropriate for your discipline. To receive help in creating a citation based on your discipline, please visit http://libguides.sjfc.edu/citations.